In 2000, Dr. Edward T. Rancic, a kidney cancer patient, enrolled in the National Heart, Lung and Blood Institute’s (NHLBI) allogeneic stem cell transplant immunotherapy clinical trial, in the research laboratory of Dr. Richard Childs in Bethesda, Maryland on the campus of the National Institutes of Health.

Through the foundation, Action to Cure Kidney Cancer (ACKC) sponsored a postdoctoral candidate’s kidney cancer research in the laboratory of Dr. Richard Childs at The National Heart Lung and Blood Institute (NHLBI).